These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38453050)

  • 1. Breast cancer stem cells as novel biomarkers.
    Ray SK; Mukherjee S
    Clin Chim Acta; 2024 Apr; 557():117855. PubMed ID: 38453050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
    Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
    Front Immunol; 2020; 11():1280. PubMed ID: 32849491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications.
    Conde I; Ribeiro AS; Paredes J
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.
    Chen W; Zhang L; Liu S; Chen C
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development.
    Zhang T; Zhou H; Wang K; Wang X; Wang M; Zhao W; Xi X; Li Y; Cai M; Zhao W; Xu Y; Shao R
    Biomed Pharmacother; 2022 Mar; 147():112616. PubMed ID: 35008001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
    Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y; Liu M
    J Hematol Oncol; 2021 Oct; 14(1):178. PubMed ID: 34715882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostics for Breast Cancer Stem Cells.
    Moon WK; Kim HS
    Adv Exp Med Biol; 2021; 1187():267-281. PubMed ID: 33983583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
    Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
    Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
    Liang ZM; Chen Y; Luo ML
    Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker.
    Lei B; Zhang XY; Zhou JP; Mu GN; Li YW; Zhang YX; Pang D
    Tumour Biol; 2016 Nov; 37(11):14757-14764. PubMed ID: 27629143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNAs in breast cancer stem cells.
    Huang Y; Mo W; Ding X; Ding Y
    Med Oncol; 2023 May; 40(6):177. PubMed ID: 37178429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs, a Promising Target for Breast Cancer Stem Cells.
    Das PK; Siddika MA; Asha SY; Aktar S; Rakib MA; Khanam JA; Pillai S; Islam F
    Mol Diagn Ther; 2020 Feb; 24(1):69-83. PubMed ID: 31758333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiple breast cancer stem cell model to predict recurrence of T
    Qiu Y; Wang L; Zhong X; Li L; Chen F; Xiao L; Liu F; Fu B; Zheng H; Ye F; Bu H
    BMC Cancer; 2019 Jul; 19(1):729. PubMed ID: 31340763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
    Zhang R; Tu J; Liu S
    Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.